Research Interests:
Research Interests:
Research Interests: Genetics()
()
Transgenic mice have been used extensively to analyze gene function. Unfortunately, traditional transgenic procedures have only limited use in analyzing alleles that cause lethality because lines of founder mice cannot be established.... more
Transgenic mice have been used extensively to analyze gene function. Unfortunately, traditional transgenic procedures have only limited use in analyzing alleles that cause lethality because lines of founder mice cannot be established. This is frustrating given that such alleles often reveal crucial aspects of gene function. For this reason techniques that facilitate the generation of embryos expressing such alleles would be of enormous benefit. Although the transient generation of transgenic embryos has allowed limited analysis of lethal alleles, it is expensive, time consuming and technically challenging. Moreover a fundamental limitation with this approach is that each embryo generated is unique and transgene expression is highly variable due to the integration of different transgene copy numbers at random genomic sites. Here we describe an alternative method that allows the generation of clonal mouse embryos harboring a single-copy transgene at a defined genomic location. This wa...
Research Interests: Technology, Stem Cells, Transgenic Mice, Polyploidy, Biological Sciences, and 15 moreCell line, Mice, Animals, Embryonic Stem Cell, Comparative Analysis, Gene Dosage, Myocardium, Gene Function, Genetic Recombination, Homologous Recombination, Limit Analysis, Transgenic Mouse Technology, Embryos, Transgene Expression, and ES cell
Research Interests:
Research Interests:
The process of bone formation can be approximated in vitro in the form of a mineralized nodule. Osteoprogenitors and mesenchymal stem cells (MSCs), the immediate precursors of the osteoprogenitor, proliferate and differentiate into... more
The process of bone formation can be approximated in vitro in the form of a mineralized nodule. Osteoprogenitors and mesenchymal stem cells (MSCs), the immediate precursors of the osteoprogenitor, proliferate and differentiate into osteoblasts when placed into culture. These osteoblasts secrete and mineralize a matrix during a period of 3-4 weeks. The differentiation potential of embryonic stem (ES) cells suggests that ES cells should also have the ability to form osteogenic nodules in vitro. ES cells were allowed to form embryoid bodies (EBs) and were cultured in suspension for 2 days; EBs were disrupted and plated as single cells at concentrations as low as 25 cells/cm(2). We provide five lines of evidence for osteogenesis in these ES cell-derived cultures: (1) cell and colony morphology as revealed by phase-contrast microscopy, (2) mineralization of extracellular matrix as revealed by von Kossa staining, (3) quantitative real-time PCR (QRT-PCR) analysis of cDNA from entire plates and individual colonies revealing expression of genes characteristic of, and specific for, osteoblasts, (4) confocal microscopy of nodules from osteocalcin-green fluorescent protein (GFP) ES cell lines demonstrating the appropriate stage and position of osteoblasts expressing the reporter, and (5) immunostaining of nodules with a type I collagen antibody. Our method of initiating osteogenesis from ES cell-derived cultures is the only described method that allows for the observation and manipulation of the commitment stage of mesengenesis from single embryonic progenitors.
Research Interests:
Research Interests:
Research Interests:
Research Interests: Proteomics, Drug development, Multidisciplinary, Blood Glucose, Insulin, and 13 moreDiabetic Retinopathy, Animals, Retina, PLoS one, mRna expression levels, Rats, Microarray Analysis, Protein Expression, Proteome analysis, Rat Model, Vascular Permeability, Quantitative Method, and Gene expression profiling
Research Interests:
Research Interests:
Research Interests:
Research Interests:
Research Interests:
This study tested the Ins2(Akita) mouse as an animal model of retinal complications in diabetes. The Ins2(Akita) mutation results in a single amino acid substitution in the insulin 2 gene that causes misfolding of the insulin protein. The... more
This study tested the Ins2(Akita) mouse as an animal model of retinal complications in diabetes. The Ins2(Akita) mutation results in a single amino acid substitution in the insulin 2 gene that causes misfolding of the insulin protein. The mutation arose and is maintained on the C57BL/6J background. Male mice heterozygous for this mutation have progressive loss of beta-cell function, decreased pancreatic beta-cell density, and significant hyperglycemia, as early as 4 weeks of age. Heterozygous Ins2(Akita) mice were bred to C57BL/6J mice, and male offspring were monitored for hyperglycemia, beginning at 4.5 weeks of age. After 4 to 36 weeks of hyperglycemia, the retinas were analyzed for vascular permeability, vascular lesions, leukostasis, morphologic changes of micro- and macroglia, apoptosis, retinal degeneration, and insulin receptor kinase activity. The mean blood glucose of Ins2(Akita) mice was significantly elevated, whereas the body weight at death was reduced compared with that of control animals. Compared with sibling control mice, the Ins2(Akita) mice had increased retinal vascular permeability after 12 weeks of hyperglycemia (P < 0.005), a modest increase in acellular capillaries after 36 weeks of hyperglycemia (P < 0.0008), and alterations in the morphology of astrocytes and microglia, but no changes in expression of Muller cell glial fibrillary acidic protein. Increased apoptosis was identified by immunoreactivity for active caspase-3 after 4 weeks of hyperglycemia (P < 0.01). After 22 weeks of hyperglycemia, there was a 16.7% central and 27% peripheral reduction in the thickness of the inner plexiform layer, a 15.6% peripheral reduction in the thickness of the inner nuclear layer (P < 0.001), and a 23.4% reduction in the number of cell bodies in the retinal ganglion cell layer (P < 0.005). In vitro insulin receptor kinase activity was reduced (P < 0.05) after 12 weeks of hyperglycemia. The retinas of heterozygous male Ins2(Akita) mice exhibit vascular, neural, and glial abnormalities generally consistent with clinical observations and other animal models of diabetes. In light of the relatively early, spontaneous onset of the disease and the popularity of the C57BL/6J inbred strain as a background for the generation and study of other genetic alterations, combining the Ins2(Akita) mutation with other engineered mutations will be of great use for studying the molecular basis of retinal complications of diabetes.
Research Interests: Genetics, Confocal Microscopy, Apoptosis, Biological Sciences, Caspases, and 17 moreHyperglycemia, Blood Glucose, Insulin, Mice, Diabetic Retinopathy, Animals, Male, Astrocyte, Retinal Degeneration, Animal Model, Astrocytes, Caspase, Glial Fibrillary Acidic Protein, Body Weight, Amino Acid Substitution Rates, Type 2 Diabetes Mellitus, and Vascular Permeability
Eight major histocompatibility complex (MHC) class II loci and the newly defined Y3/Ring 4 locus were isolated in overlapping yeast artificial chromosome (YAC) clones defining a 420-kb segment of human chromosome 6p21.3. YAC B1D12... more
Eight major histocompatibility complex (MHC) class II loci and the newly defined Y3/Ring 4 locus were isolated in overlapping yeast artificial chromosome (YAC) clones defining a 420-kb segment of human chromosome 6p21.3. YAC B1D12 spanning 320 kb contained seven of these loci from HLA-DRA to HLA-DQB2. A 330-kb YAC, A148A7, spanned from the HLA-DQA1 locus through the Y3/Ring 4 locus and extended at least 130 kb centromeric of YAC B1D12. Southern blotting demonstrated that YAC B1D12 derived from the HLA-DR3 haplotype and that YAC A148A7 derived from the HLA-DR7 haplotype of the heterozygous library donor. A third 150-kb YAC, A95C5, lay within this contig and contained only the HLA-DRA locus. A fourth 300-kb YAC, A76F11, was isolated by chromosome walking from the telomeric end of YAC B1D12. Probes isolated from the ends of the YAC genomic inserts have been used to confirm overlaps between the clones. These analyses demonstrated that the centromeric end of YAC A76F11 used the same genomic EcoRI cloning site as the telomeric end of YAC A95C5. YAC B1D12 used an EcoRI site only 2.1 kb telomeric of the aforementioned EcoRI site. These data suggest that certain EcoRI sites are used preferentially during construction of the library. These YACs complete the linkage of the DR and DQ subregions of the HLA complex in cloned DNA and provide the substrate for precise analysis of this portion of the class II region.
Research Interests:
Research Interests:
Research Interests:
Research Interests: Obesity, Diet, Energy Metabolism, Adipose tissue, Humans, and 18 moreProtein Turnover, Protein Kinases, Insulin, Mice, Female, Animals, Male, Proteins, Energy Expenditure, Eating, Gene Targeting, Body Weight, Thermogenesis, Glucose Tolerance Test, Sirolimus, Oxygen Consumption, Biochemistry and cell biology, and Transaminases
Research Interests: Genetics, Biometry, Type 2 Diabetes, Gene expression, Blood Glucose, and 17 moreInsulin, Diabetes mellitus, Diabetic Retinopathy, Animals, Male, Retina, Polymerase Chain Reaction, Gene Regulatory Networks, mRna expression levels, Rats, Protein Expression, Reproducibility of Results, Streptozotocin, Diabetic Rat, DNA probes, Gene Expression Regulation, and Gene expression profiling(Insulin, Diabetes mellitus, Diabetic Retinopathy, Animals, Male, Retina, Polymerase Chain Reaction, Gene Regulatory Networks, mRna expression levels, Rats, Protein Expression, Reproducibility of Results, Streptozotocin, Diabetic Rat, DNA probes, Gene Expression Regulation, and Gene expression profiling)
(Insulin, Diabetes mellitus, Diabetic Retinopathy, Animals, Male, Retina, Polymerase Chain Reaction, Gene Regulatory Networks, mRna expression levels, Rats, Protein Expression, Reproducibility of Results, Streptozotocin, Diabetic Rat, DNA probes, Gene Expression Regulation, and Gene expression profiling)